Villegas-Mendez A - Search Results

1

Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.

Rothe R, Liguori L, Villegas-Mendez A, Marques B, Grunwald D, Drouet E, Lenormand JL. Rothe R, et al. J Biol Chem. 2010 Jun 25;285(26):20224-33. doi: 10.1074/jbc.M110.101550. Epub 2010 Apr 9. J Biol Chem. 2010. PMID: 20385549 Free PMC article.

2

Functional characterisation of the WW minimal domain for delivering therapeutic proteins by adenovirus dodecahedron.

Villegas-Méndez A, Fender P, Garin MI, Rothe R, Liguori L, Marques B, Lenormand JL. Villegas-Méndez A, et al. PLoS One. 2012;7(9):e45416. doi: 10.1371/journal.pone.0045416. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23028993 Free PMC article.

3

Production of membrane proteins using cell-free expression systems.

Liguori L, Marques B, Villegas-Méndez A, Rothe R, Lenormand JL. Liguori L, et al. Expert Rev Proteomics. 2007 Feb;4(1):79-90. doi: 10.1586/14789450.4.1.79. Expert Rev Proteomics. 2007. PMID: 17288517 Review.

4

Liposome-mediated cellular delivery of active gp91(phox).

Marques B, Liguori L, Paclet MH, Villegas-Mendéz A, Rothe R, Morel F, Lenormand JL. Marques B, et al. PLoS One. 2007 Sep 12;2(9):e856. doi: 10.1371/journal.pone.0000856. PLoS One. 2007. PMID: 17848987 Free PMC article.

5

Liposomes-mediated delivery of pro-apoptotic therapeutic membrane proteins.

Liguori L, Marques B, Villegas-Mendez A, Rothe R, Lenormand JL. Liguori L, et al. J Control Release. 2008 Mar 20;126(3):217-27. doi: 10.1016/j.jconrel.2007.12.004. Epub 2007 Dec 14. J Control Release. 2008. PMID: 18234390

6

In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.

Villegas-Mendez A, Garin MI, Pineda-Molina E, Veratti E, Bueren JA, Fender P, Lenormand JL. Villegas-Mendez A, et al. Mol Ther. 2010 May;18(5):1046-53. doi: 10.1038/mt.2010.16. Epub 2010 Feb 23. Mol Ther. 2010. PMID: 20179681 Free PMC article.

7

Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3.

Villegas-Mendez A, Montes R, Ambrose LR, Warrens AN, Laffan M, Lane DA. Villegas-Mendez A, et al. J Thromb Haemost. 2007 May;5(5):980-8. doi: 10.1111/j.1538-7836.2007.02480.x. J Thromb Haemost. 2007. PMID: 17459006 Free PMC article.

8

Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation.

Preston RJ, Villegas-Mendez A, Sun YH, Hermida J, Simioni P, Philippou H, Dahlbäck B, Lane DA. Preston RJ, et al. FEBS J. 2005 Jan;272(1):97-108. doi: 10.1111/j.1432-1033.2004.04401.x. FEBS J. 2005. PMID: 15634335 Free article.

9

Identification and characterization of a natural R96C EPCR variant.

Hermida J, Hurtado V, Villegas-Mendez A, Catto AJ, Philippou H. Hermida J, et al. J Thromb Haemost. 2003 Aug;1(8):1850-2. doi: 10.1046/j.1538-7836.2003.00318.x. J Thromb Haemost. 2003. PMID: 12911608 Free article. No abstract available.

10

Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection.

Dookie RS, Villegas-Mendez A, Cheeseman A, Jones AP, Barroso R, Barrett JR, Draper SJ, Janse CJ, Grogan JL, MacDonald AS, Couper KN. Dookie RS, et al. Among authors: villegas mendez a. Infect Immun. 2024 Nov 12;92(11):e0034524. doi: 10.1128/iai.00345-24. Epub 2024 Sep 26. Infect Immun. 2024. PMID: 39324794 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters